Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company’s more than 60,000 employees serve clients in over 100 countries, worked on over 80% of the new drugs approved by the FDA in 2022 and performed more than 600 million tests for patients around the world. Learn more about us at www.labcorp.com. | Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company’s nearly 70,000 employees serve clients in approximately 100 countries, provided support for more than 75% of the new drugs and therapeutic products approved in 2024 by the FDA, and perform more than 700 million tests annually for patients around the world. Learn more about us at www.labcorp.com. Invitae is a part of Labcorp. | We are a global life sciences and healthcare company harnessing science for human good. Every day, our mission is to improve health and improve lives. | Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company’s nearly 70,000 employees serve clients in approximately 100 countries, provided support for more than 75% of the new drugs and therapeutic products approved in 2024 by the FDA, and perform more than 700 million tests annually for patients around the world. Learn more about us at https://www.labcorp.com/infectious-disease.
Kyongbo Pharmaceutical. Co., Ltd
Since its establishment in 1987, Kyongbo Pharmaceutical has grown into one of Korea’s leading API pharmaceutical companies, supplying raw materials to more than 30 countries at home and abroad. We strive to advance the standards of pharmaceutical manufacturing and quality control and have successfully achieved a track record in various regulatory agencies around the world, including the FDA, EDQM, PMDA, NMPA, and MFDS. Kyongbo Pharmaceutical has been investing in facilities and research and development for decades. We have expanded our business into the field of ADCs, providing CDMO services. We provides comprehensive services for ADCs to help clients’ discovery from early development through pre-clinical, clinical and commercial manufacturing. We offer integrated services including payloads production, linker production, conjugation development, analytical method development, and sterile fill/finish. As a trusted CDMO partner, we provide integrated CDMO services for ADCs production to meet the needs of clients.
Korea Pavilion
Korea Biotechnology Industry Organization (KoreaBIO) is an association established as a result of merger between three different industry associations in the biotechnology field in November 2008. KoreaBIO promotes communication among all bio-industry related organizations and is striving to create a sustainable biotechnology industry ecosystem. KoreaBIO is a central organization with around 600 members from major pharma & biotechnology enterprises to special members, representing the biotechnology industry of Korea. KoreaBIO also develops various training and policy-making programs to serve the member companies more efficiently and promotes co-operation, investment relations, and technological collaborations around the world. | . | X | The Korea Pavilion at the 2026 BIO International Convention (BIO USA) brings together a curated group of leading Korean biopharmaceutical and healthcare companies, showcasing the innovation and global competitiveness of Korea’s bioindustry. The pavilion will feature approximately 50 Korean companies spanning key sectors including novel drug development, biopharmaceutical manufacturing, advanced therapeutics, healthcare technologies, and digital health services. Located at Booth 3735 in the San Diego Convention Center, the Korea Pavilion serves as a central hub for global partnering, investment, and strategic collaboration between Korean innovators and international biopharma stakeholders. | Korea Creative Content Agency (KOCCA) leads the innovative growth of K-content, supporting games, broadcasting, animation, characters, comics/webtoons, stories, music, fashion, and new tech convergence. We foster IP planning, creation, distribution, global expansion, talent, R&D, finance, and policy. At IAAPA Expo 2025, we present the Korea Pavilion with POCKET JACKS Inc., MOERS Inc., QLAB, ILSUNG METAL FREE Co., and KOMUSE Ltd. Visit to explore K-Arcade, join fun events, and receive gifts.
Kolon Biotech, Inc.
Kolon Biotech is a trusted CDMO partner specializing in Cell & Gene and Exosome Therapy. Our team of experts, with extensive experience in various cell types including somatic cells, stem cells, immune cells, and iPSCs, oversees the entire manufacturing process. We are dedicated to operational excellence in GMP manufacturing and quality assurance, ensuring value delivery to our clients. Our service offers solutions aimed at shortening time-to-market, enhancing efficiency, and alleviating regulatory burdens. 1. Tailored Services – With extensive experience in various cell types including somatic cells, stem cells, immune cells, and iPSCs, we provide end-to-end services with cGMP regulation. For the product development, we can support the cell Banking and preclinical batch production. In the early stages of clinical development, we support clients to achieve their R&D milestones at reasonable costs. In the late stages of pipeline development, we provide expertise to secure cost effectiveness and production efficiency to achieve successful commercialization. With fast production timeline with client’s development plan, we can deliver a tox batch within 3.5 months from project initiation and supply investigational products within 6 months. 2. Innovative Technologies – Conventional 2D Process: Managing a variety of culture vessels such as KI 75, Hyper Flask, Hyper Stack, and Cell Factory. We provide optimal freezing and storage conditions for mass products using CRF (Controlled Rate Freezer). To ensure safety of the transduced cell-line, we have established an irradiation system. You can select the appropriate type of irradiation according to your needs. – 2D Automated Closed Platform: Kolon Biotech’s platform can manufacture adherent cells in large scale with competitive costs and minimum contamination risk. With an automated system using a machine manipulator; we can set up the operation conditions and minimize human error ensuring batch-to- batch consistency. This technology can provide a fully closed process from seeding to filling using welding system and bag type filtration.
KINSY
Spanish CDMO focused on optimisation and manufacturing of Drug Substances at pre-clinical, clinical and commercial stages. Our capabilities are summarised as follow: -R&D Centre / GMP Kilolab (5ML-10L). -GMP Pilot Plant (10L-400L) including cryogenic reactors, hydrogenation and large flash-chromatography capacity. -GMP Manufacturing Plant (1000L-6300L) including cryogenic reactors and hydrogenation.
Kentucky Pavilion
Trifecta Kentucky is a coalition led by Greater Louisville Inc.’s Health Enterprises Network, comprised of 22 counties within central Kentucky and Southern Indiana. It’s home to 2.2 million people and within a day’s drive of 2/3 of the U.S. population. And it’s a region that offers highly competitive advantages within the logistics, life sciences and pharmaceutical sectors. For this region, the Trifecta is not just a term in Kentucky’s signature horse racing industry. Trifecta Kentucky is all about advantages in Lifestyle, Logistics, and Life sciences that make it the perfect place to do business. | Trifecta Kentucky (3KY) is a state coalition led by the Metro Chamber of Commerce, Greater Louisville Inc.’s Health Enterprises Network. Our region is home to 2.2 million people and within a day’s drive of 2/3 of the U.S. population. There are 80+ non-stop destination flights and several international flights between Louisville, Lexington, and Northern KY/Cincinnati. Kentucky offers highly competitive advantages within the Logistics, Life Sciences, and Pharmaceutical sectors. Consider our region for developing and manufacturing medically sensitive materials, providing testing, lab and tissue-banking services, or being the hub of personalized or regenerative medical treatment solutions. Kentucky is filled with spectacular lakes and bluegrass parks, outdoor activities and renowned cultural attractions. It’s home to Churchill Downs, Keeneland; a tourist favorite of bordering neighbors from seven states in the Midwest and the Southeast. And it’s a food lover’s paradise. The perfect place to do business.
Kentucky Cabinet for Economic Development
Kentucky Cabinet for Economic Development creates a sustainable and active entrepreneurial ecosystem throughout the Commonwealth that is designed to identify, develop, retain and attract talented entrepreneurs utilizing an approach that focuses on inclusivity, connectivity, positivity, and a “give first” culture. KY Innovation, within the KY Cabinet for Economic Development, administers Kentucky’s SBIR/STTR Matching Funds Program. | As the primary state agency encouraging job creation, retention and business investment in Kentucky, the Cabinet for Economic Development works to attract new industries and assists existing companies to grow and expand. The Cabinet also provides support and resources for entrepreneurs, startups and small business owners. As well, it helps prepare communities for economic development opportunities. In addition to the Cabinet’s central office in Frankfort, KY, the Cabinet maintains international offices in Europe and Asia.
Kemwell Biopharma Private Ltd.
Kemwell is a biologics focused Contract Development and Manufacturing (CDMO) company providing services to global biopharmaceutical organisations. Kemwell’s facilities, located in Bangalore, India, are designed with technological support from a leading German biopharma company.The team is experienced to undertake end-to-end activities right from cell line development till cGMP clinical and commercial manufacturing. Kemwell also undertakes standalone projects such as process optimisation, analytical method development or validation, formulation development and optimization, stability studies, resin reuse study, tech transfer and cGMP manufacturing, process characterization, etc. We are currently supplying commercial mAb in 35 plus countries and have worked with US innovator/biotech companies to accelerate development for their pipeline drugs since 2012. | As a trusted biologics CDMO partner we provide end-to-end service from clinical development to commercial-scale manufacturing, we have an extensive process characterization infrastructure and experience in process development including complex mAbs – (Bispecific, Trispecific, ADC and Complex fusion proteins), Analytical Development (Bioassays, Mass Spec, and SPR), and formulation development (in-house stability studies, Liquid, Lyo, and high concentration protein formulation). To enhance our drug product fill-finish capabilities, we have introduced the OPTIMA Pre-Filled Syringe line, in addition to our existing liquid and lyophilized vial offerings. | Kemwell has 40+ years of experience being a CDMO based out of Bangalore, India and provides services to global biopharmaceutical organisations. Our FDA-approved site supports end-to-end biologics programs from development to commercial supply and features: • 5000L+ upstream capacity with single-use and stainless-steel bioreactors • Commercial fill-finish lines for liquid vials, lyo vials and pre-filled syringes with isolator technology • Capabilities across monoclonals, bispecifics/tri-specifics, fusion proteins, biosimilars
Kaneka Eurogentec
Founded in 1985 and part of Kaneka Corporation since 2010, Eurogentec is a leading biotechnology and CDMO company specializing in GMP-certified manufacturing of starting materials and APIs. With facilities in Europe and the USA, we support plasmid DNA, mRNA, recombinant proteins, peptides, antibody fragments, and therapeutic oligonucleotides from early research to clinical and commercial production. Our expertise in process development and scale-up ensures high-quality solutions at every stage. Detailed Description of Products (Event Specific) max 500 characters in English – Plasmid DNA – Starting material & APIs including Nano-plasmids & Minicircle DNA. FastTrack: 4-month production. – mRNA – IVT mRNA (0.1g–50g), saRNA, gRNA with co-/post-transcriptional modifications. – Proteins – GMP production in E. coli & P. pastoris for biotech & pharma. – Conjugates – Chemically modified recombinant proteins for clinical use. – Therapeutic Oligos – ASOs, siRNA, aptamers, CpG oligos. – Peptides – Linear, cyclic & complex-modified. – Antibody Fragments – scFv, Fab, VHH, bispecifics.
K-BIO Materials, Parts and Equipment Special Pavilion Hosted by KEIT
Korea Planning & Evaluation Institute of Industrial Technology (KEIT) specializes in the planning, evaluation, and management of national R&D projects in industrial technology under the Ministry of Trade, Industry and Energy (MOTIE). Our Materials, Parts and Equipment (MPE) Pavilion includes the following companies: ① JEIO TECH CO., LTD. Reliable manufacturer for biology, chemistry, medicine, and pharmacology | labcompanionshop.com ② MICRODIGITAL CO., LTD. Biomedical and bioprocess innovation | md-best.com/en ③ CELLSAFE CO., LTD. Mycoplasma testing, replication competent virus, host cell DNA | cells-safe.com ④ DUKSAN PURE CHEMICALS GMP-compliant high-purity solvents | duksan.kr ⑤ ECONITY CO., LTD. Membrane manufacturing for advanced applications | econity.com ⑥ AMICOGEN INC. CDMO for cell culture media and chromatography resins | amicogen.com/en